BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24530159)

  • 1. Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia.
    Torgalsbøen AK; Mohn C; Rishovd Rund B
    Psychiatry Res; 2014 Apr; 216(1):1-5. PubMed ID: 24530159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neurocognition and functional recovery in first-episode schizophrenia: Results from the second year of the Oslo multi-follow-up study.
    Torgalsbøen AK; Mohn C; Czajkowski N; Rund BR
    Psychiatry Res; 2015 Jun; 227(2-3):185-91. PubMed ID: 25890693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
    Lystad JU; Falkum E; Haaland VØ; Bull H; Evensen S; Bell MD; Ueland T
    Schizophr Res; 2016 Jan; 170(1):143-9. PubMed ID: 26692347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Fu S; Czajkowski N; Rund BR; Torgalsbøen AK
    Schizophr Res; 2017 Dec; 190():144-149. PubMed ID: 28302394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Schizophr Res; 2014 Sep; 158(1-3):113-9. PubMed ID: 25008791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.
    Rund BR; Barder HE; Evensen J; Haahr U; ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld J; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Sundet K; Vaglum P; McGlashan T; Friis S
    Schizophr Bull; 2016 Jan; 42(1):87-95. PubMed ID: 26101305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
    Jaracz K; Górna K; Kiejda J; Grabowska-Fudala B; Jaracz J; Suwalska A; Rybakowski JK
    Eur Psychiatry; 2015 Nov; 30(8):907-13. PubMed ID: 26647865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Melau M; Forchhammer HB; Nordentoft M
    Schizophr Res; 2012 Nov; 141(2-3):251-6. PubMed ID: 23017825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of premorbid adjustment, neurocognition, and depression on social and role functioning in patients in an early psychosis treatment program.
    Minor KS; Friedman-Yakoobian M; Leung YJ; Meyer EC; Zimmet SV; Caplan B; Monteleone T; Bryant C; Guyer M; Keshavan MS; Seidman LJ
    Aust N Z J Psychiatry; 2015 May; 49(5):444-52. PubMed ID: 25586755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Bergh S; Hjorthøj C; Sørensen HJ; Fagerlund B; Austin S; Secher RG; Jepsen JR; Nordentoft M
    Schizophr Res; 2016 Aug; 175(1-3):57-63. PubMed ID: 27050475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.